CLINICAL_TRIALS
trial_result
· 2021-01-15
Clinical Trial Update: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease [Phase 2]
Summary
A Phase 2 trial investigating low-dose pioglitazone for autosomal dominant polycystic kidney disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Polycystic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-01-15